Extreme neonatal hyperbilirubinemia and a specific genotype: a population-based case-control study

Area of Science:

• Neonatology
• Medical Genetics
• Biochemistry

Background:

• Extreme hyperbilirubinemia poses a significant risk for bilirubin encephalopathy.
• While risk factors exist, the cause of hyperbilirubinemia remains unknown in many cases.
• UGT1A1 enzyme activity is crucial for bilirubin metabolism, and the UGT1A1*28 allele reduces this activity.

Purpose of the Study:

• To investigate the association between the UGT1A1*28 allele and extreme hyperbilirubinemia in infants.
• To determine if the UGT1A1*28 allele, associated with Gilbert syndrome, is a risk factor for elevated bilirubin levels.

Main Methods:

• A case-control study was conducted in Denmark involving 231 infants with extreme hyperbilirubinemia and 432 controls.
• The UGT1A1*28 allele was genotyped using samples from the Danish Neonatal Screening Biobank.
• Subgroup analysis was performed for cases with ABO incompatibility.

Main Results:

• No statistically significant association was found between the UGT1A1*28 allele and extreme hyperbilirubinemia.
• Odds ratios for extreme hyperbilirubinemia were 0.87 for heterozygotes and 0.77 for homozygotes compared to the common genotype.
• The UGT1A1*28 allele was also not associated with extreme hyperbilirubinemia in ABO incompatible cases.

Conclusions:

• The UGT1A1*28 allele is not a risk factor for developing extreme hyperbilirubinemia in the studied population.
• This finding clarifies the role of Gilbert syndrome genetics in neonatal hyperbilirubinemia.